Wilmington will still be AstraZeneca's North American headquarters for sales and marketing, with about 2,000 employees remaining. The other 250 jobs being cut in Wilmington include 80 going to a site in Waltham, Massachusetts, and about 170 going to other U.S. or overseas locations. In the ...
Headquarters London, England, UK Key people David Brennan CEOTony Zook Vice President, North AmericaLouis Schweitzer ChairmanSimon Lowth CFOJohn Patterson CBE Executive Director, Development Industry Pharmaceutical Products Pharmaceutical products for humans Revenue $26.48 billion (2006)[1] Operating income ...
moving the company’s headquarters to its R&D hub in Cambridge, U.K.; re-focusing on emerging markets, where AZ already gets $6 billion in sales, especially China. But the short-term key to delivering on his promises today seems to come down to a single drug: Brilinta, the Plavix compe...
AstraZeneca PLC is one of the world's leading pharmaceutical companies. Its corporate headquarters are in London, its research and development headquarters are in Södertälje, Sweden, and it has manufacturing facilities in 19 different countries. The company operates nine research and development si...